Surveillance Mammography After Treatment For Primary Breast Cancer

Main Category: Breast Cancer
Also Included In: MRI / PET / Ultrasound
Article Date: 15 Sep 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The National Institute for Health Research Health Technology Assessment (NIHR HTA) programme has commissioned a new study to identify the most effective and efficient surveillance methods for women who have received treatment for primary breast cancer. There are 45,000 new cases in the UK each year and although the majority of women never experience a recurrence, it does return in approximately 25 per cent of women. The majority of these recurrences are found during the first three years after treatment.

It is generally accepted that early diagnosis is a key factor influencing survival from breast cancer, with an 81 per cent reduction in mortality compared with women who were identified with more advanced stages. A recurrence of breast cancer might be found either by physical examination or by mammography, a process which uses low-dose X-rays to examine the breast. There is, however, no general agreement as to the best way to monitor patients for recurrence or how often women should receive X-rays.

The study, lead by Professor Fiona Gilbert of the University of Aberdeen is re-examining the data from existing research studies as well as data from clinicians and hospitals to assess the potential for reducing mortality through earlier detection of breast cancer while also considering the potential harms. The project will also investigate the cost-effectiveness of using mammography on a regular basis to identify the most appropriate method and recurrence.

Professor Gilbert says, "The key factor is to identify the best method for mammographic surveillance for patients after breast cancer treatment. In addition, we aim to look at alternative methods over the next three years to ascertain the most effective procedure for aftercare treatment and to estimate the cost-effectiveness of alternative follow-up schemes. In time we hope this will lead to an improvement in survival of women through a more efficient monitoring system."

Helen Nikandrou
Assistant Programme Manager
(HTA Communications Division)

Health Technology Assessment (HTA) programme managed by the National Institute for Health Research (NIHR)

The NIHR HTA programme is managed by the NIHR Coordinating Centre for Health Technology Assessment (NCCHTA). The NCCHTA is part of the NIHR Evaluation, Trials and Studies Coordinating Centre (NETS-CC), based at the University of Southampton.

http://www.hta.ac.uk
http://www.soton.ac.uk

Article adapted by Medical News Today from original press release.
Visit our breast cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
National Institute for Health Research Health Tech. "Surveillance Mammography After Treatment For Primary Breast Cancer." Medical News Today. MediLexicon, Intl., 15 Sep. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/121465.php>

APA
National Institute for Health Research Health Tech. (2008, September 15). "Surveillance Mammography After Treatment For Primary Breast Cancer." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/121465.php.

Please note: If no author information is provided, the source is cited instead.


Breast Cancer

What Is Breast Cancer?

Breast cancer is a tumor that has become malignant - it has developed from the breast cells. A 'malignant' tumor can spread to other parts of the body - it may also invade surrounding tissue. When it spreads around the body, we call it 'metastasis'. Read more...

Most Popular Articles



Follow Our Breast Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Breast Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »